About Avandia (Rosiglitazone)
Editor: Robert J. Binstock
Profession: Avandia Attorney
May 12, 2007
Category: About Avandia
Rosiglitazone, approved in 1999, is an anti-diabetic drug used to treat people with type 2 diabetes. Rosiglitazone is in the thiazolidinedione class and marketed under the brand name Avandia, by the pharmaceutical company GlaxoSmithKline.
Avandia works by helping to restore the body's proper response to insulin, thereby lowering blood sugar.
Effectively controlling high blood sugar helps patients to prevent kidney disease, blindness, strokes, heart disease and in come cases, sexual function problems. Avandia is used alone or in combination with other anti-diabetic medication.
In recent studies it has been indicated that Avandia may benefit those that suffer from Alzheimer's disease expressing the ApoE4 allelle. In fact, GlaxoSmithKline is currently heading a clinical trial on this subject.
TrackBack URL for this entry: